Neko Health runs the Neko Health Scan, a 60-minute comprehensive, non-invasive, radiation-free assessment that captures millions of health data points using proprietary sensors alongside blood analysis and delivers results with an in-person clinician consultation. Since launching in February 2023, Neko has expanded clinics across Sweden and the U.K., recently opening a new Stockholm clinic and rolling out next-generation devices (Derma-2, Echo-2, Spectrum-2) and body-composition measures. Over 350,000 people have registered for a scan and more than 100,000 members have completed one, with about 75% of members prepaying for a follow-up scan at the end of their appointment. Neko reports measurable health improvements for returning members, including statistically significant improvements in five of seven key biomarkers and many previously severe conditions brought under control. The company is focused on scaling clinic footprint and iterating its in-house tech stack, with planned U.S. expansion and continued investment in hardware and its health data platform.

Total raised

$1.0B

Funding rounds

3

Latest round

Series C

Latest activity

Jul 2026